Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Director departure
Appointed director
|
|
PRESSURE BIOSCIENCES INC (PBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ...|
Docs:
|
"CERTIFICATE OF DESIGNATION OF SERIES BB CONVERTIBLE PREFERRED STOCK OF PRESSURE BIOSCIENCES, INC. 1. Series BB Preferred Stock Designation and Rank . Designation. The designation of such series of the Preferred Stock shall be the Series BB Convertible Preferred Stock, par value $0.01 per share . The maximum number of shares of Series BB Preferred Stock shall be One Thousand shares. Rank. The Series BB Preferred Stock shall rank prior to the common stock, par value $0.01 per share of Pressure BioSciences, Inc. , and subordinate to the Series AA and Series CC Preferred Stock, and to all other classes and series of equity securities of the Company which by its terms does not rank on a parity with or senior to the Series BB Preferred Stock . The Series BB Preferred Stock shall be subordinate t...",
"CERTIFICATE OF DESIGNATION OF SERIES CC CONVERTIBLE PREFERRED STOCK OF PRESSURE BIOSCIENCES, INC. 1. Series CC Preferred Stock Designation and Rank . Designation. The designation of such series of the Preferred Stock shall be the Series CC Convertible Preferred Stock, par value $0.01 per share . The maximum number of shares of Series CC Preferred Stock shall be Two Thousand shares. Rank. The Series CC Preferred Stock shall rank prior to the common stock, par value $0.01 per share , shall rank pari passu to the Series AA Preferred Stock, and shall rank prior to all other classes and series of equity securities of the Company which by its terms does not rank on a parity with or senior to the Series CC Preferred Stock . The Series CC Preferred Stock shall be subordinate to and rank junior to ..." |
|
| 03/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities Interactive Data |
| 01/05/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 01/04/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 08/20/2021 |
8-K
| Quarterly results |
| 12/31/2020 |
8-K
| Quarterly results |
| 12/09/2020 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 11/06/2020 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 10/09/2020 |
8-K
| Quarterly results |
| 07/08/2020 |
8-K
| Quarterly results |
| 05/15/2020 |
8-K
| Quarterly results |
| 03/06/2020 |
8-K
| Quarterly results |
| 02/05/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities |
| 12/27/2019 |
8-K
| Quarterly results |
| 09/20/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/16/2019 |
8-K
| Regulation FD Disclosure |
| 05/01/2019 |
8-K
| Quarterly results |
| 02/15/2019 |
8-K
| Quarterly results |
| 12/17/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/12/2018 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 11/14/2018 |
8-K
| Regulation FD Disclosure |
| 06/15/2018 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 12/27/2017 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 12/18/2017 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"Asset Purchase Agreement between Pressure BioSciences, Inc. and BaroFold, Inc.",
"Pressure BioSciences Announces Acquisition of All Assets of BaroFold, Inc. Acquisition to Combine BaroFold’ s Patented High-Pressure Protein Refolding Technology with PBI’ s Leadership in High-Pressure Instrumentation and Worldwide Market Access. Company Plans Immediate Entry into the Biologics Contract Research Services Sector. South Easton, MA, December 13, 2017 – Pressure BioSciences, Inc. , a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry, today announced the acquisition of all assets of BaroFold, Inc. Among the assets acquired were all patents, equipment, and intellectual property relating to BaroFold’ s PreEMT ™ high-pressure protein refolding technology. PreEMT is a patented technology that ..." |
|
| 06/22/2017 |
8-K
| Quarterly results |
| 05/26/2017 |
8-K
| Form 8-K - Current report |
| 04/24/2017 |
8-K
| Form 8-K - Current report |
| 04/14/2017 |
8-K
| Form 8-K - Current report |
| 12/28/2016 |
8-K
| Form 8-K - Current report |
| 11/03/2016 |
8-K
| Form 8-K - Current report |
| 04/06/2016 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
| 12/17/2012 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 11/07/2012 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 11/02/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|
|